News | June 01, 2015

IBA Reduces Energy-related Costs of Proton Therapy

Breakthrough in proton accelerator’s technology reduces isochronous cyclotron power consumption by 30 percent

IBA, new feature, energy-related costs, proton therapy, cyclotron

June 1, 2015 — IBA (Ion Beam Applications S.A) announced the release of an exclusive feature that reduces the power consumption of IBA proton therapy 230 MeV isochronous cyclotron (C230) by more than 30 percent. This unique feature helps reduce the overall cost of proton therapy, making it ever more accessible to patients worldwide.

First measurements at the Institut Curie’s Orsay Proton Therapy Center (France) show that the power consumption of the cyclotron has been lowered by an average of 30 percent over a month’s period.

IBA reported that the new feature can be retrofitted to all of its existing systems, helping customers significantly reduce their energy bills, and therefore the overall operation costs of proton therapy centers.

For more information: www.iba-worldwide.com

Related Content

Merit Medical Completes Acquisition of Cianna Medical
News | Women's Health | November 14, 2018
Disposable device manufacturer Merit Medical Systems Inc. announced the closing of a definitive merger agreement to...
Videos | ASTRO | November 08, 2018
ITN Editor Dave Fornell took a tour of some of the most innovative technologies on display on the expo floor at the 
The Fujifilm FCT Embrace CT System displayed for the first time at ASTRO 2018.
360 Photos | 360 View Photos | November 07, 2018
Fujifilm's first FDA-cleared compu...
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for radiation therapy displayed for the first time since gaining FDA clearance in 2018. It was displayed at the American Society for Radiotherapy and Oncology (ASTRO) 2018 annual meeting. Read more about this system at ASTRO 2018. #ASTRO18 #ASTRO2018
360 Photos | 360 View Photos | November 07, 2018
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for...
GE Healthcare Discovery RF Gen 2 system displayed at ASTRO 2018. It is a dedicated computed tomography (CT) scanner for radiation oncology
360 Photos | 360 View Photos | November 07, 2018
This is the GE Healthcare Discovery RF Gen 2 system displayed at the ...
Proton Therapy for Pediatric Brain Tumors Has Favorable Cognitive Outcomes
News | Proton Therapy | November 06, 2018
Proton therapy treatment for pediatric brain tumor patients is associated with better neurocognitive outcomes compared...
Videos | Radiation Oncology | November 06, 2018
Genomics can be used to assess a patient's radiosensitivity, which can be used to increase or decrease the radiation
150-Year-Old Drug Might Improve Radiation Therapy for Cancer
News | Radiation Therapy | November 02, 2018
November 2, 2018 — A drug first identified 150 years ago and used as a smooth-muscle relaxant might make tumors more